FDA panel review triggers suspension of Grail's stock trading

FDA panel review triggers suspension of Grail's stock trading

The U. S. Food and Drug Administration’s advisory committee reviewed Grail Inc.

’s multi-cancer early-detection blood test and temporarily halted trading of the company’s shares on September 24, 2026. Earlier, on September 21, 2026, Grail’s shares jumped more than 30% after the company released briefing documents ahead of the FDA panel meeting, Investor's Business Daily reported.

参与者

Grail Inc. Food and Drug Administration

地点

United States

文章

2026年九月24日
3 篇总计
Why Everpure Stock Is Surging To Record Highs
Why Everpure Stock Is Surging To Record Highs

Investor's Business Daily • 09月24日 15:18

The U.S. Food and Drug Administration’s advisory committee examined Grail's multi-cancer early detection blood test, leading to a temporary halt in trading of the company’s stock.

可信度 72% 操纵 9% 中立
Tesla Semi Joins Parade Of New Model Showcases; Stock Falls
Tesla Semi Joins Parade Of New Model Showcases; Stock Falls

Investor's Business Daily • 09月24日 15:12

The U.S. Food and Drug Administration’s advisory committee examined Grail's multi-cancer early detection blood test, leading to a temporary halt in trading of the company’s stock.

可信度 72% 操纵 9% 中立
Stock Market Today: Dow Falls On Rising Treasury Yields; Nvidia Stock Slides
Stock Market Today: Dow Falls On Rising Treasury Yields; Nvidia Stock Slides

Investor's Business Daily • 09月24日 12:04

The U.S. Food and Drug Administration’s advisory committee examined Grail's multi-cancer early detection blood test, leading to a temporary halt in trading of the company’s stock.

可信度 72% 操纵 9% 中立
2026年九月23日
1 篇总计
The Holy Grail In Cancer? FDA Panel Backs Blood Tests
The Holy Grail In Cancer? FDA Panel Backs Blood Tests

Investor's Business Daily • 09月23日 22:44

The U.S. Food and Drug Administration’s advisory committee examined Grail's multi-cancer early detection blood test, leading to a temporary halt in trading of the company’s stock.

可信度 72% 操纵 9% 中立
2026年九月22日
1 篇总计
Viking Therapeutics Stock Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.
Viking Therapeutics Stock Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.

Investor's Business Daily • 09月22日 11:37

Grail's stock rose more than 30% after briefing documents were released before a Food and Drug Administration panel meeting on its blood test for early cancer detection.

可信度 68% 操纵 35% 中立
2026年九月21日
1 篇总计
Grail Stock Catapults 30%-Plus As FDA Mulls Cancer-Detecting Blood Test
Grail Stock Catapults 30%-Plus As FDA Mulls Cancer-Detecting Blood Test

Investor's Business Daily • 09月21日 20:14

Grail's stock rose more than 30% after briefing documents were released before a Food and Drug Administration panel meeting on its blood test for early cancer detection.

可信度 68% 操纵 35% 中立